A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Hoffmann-La Roche
Pfizer
Merck Sharp & Dohme LLC
Compass Therapeutics
Revolution Medicines, Inc.
Pfizer
Seagen Inc.
GlaxoSmithKline
Elicio Therapeutics
Medtronic - MITG
Delcath Systems Inc.
Pfizer
Accent Therapeutics
Averto Medical, Inc.
A2 Biotherapeutics Inc.
Revolution Medicines, Inc.
GlaxoSmithKline
GlaxoSmithKline
Immunophotonics, Inc.
Novartis
Var2 Pharmaceuticals
Novartis
GlaxoSmithKline
Colospan Ltd.
Chongqing Precision Biotech Co., Ltd
A2 Biotherapeutics Inc.
Elicio Therapeutics
Pfizer
SafeHeal Inc
ModeX Therapeutics, An OPKO Health Company
Medicine Invention Design, Inc
Shanghai Cingularbio Co. Ltd
GILongevity
Mirati Therapeutics Inc.
Amal Therapeutics
ADVANCED MARKER DISCOVERY S.L.
Hutchmed
Chongqing Precision Biotech Co., Ltd
NantBioScience, Inc.
UTC Therapeutics Inc.
Nakhia Impex LLC
Gilead Sciences
Corvus Pharmaceuticals, Inc.
Chongqing Precision Biotech Co., Ltd
Klus Pharma Inc.
Eisai Inc.
Advaxis, Inc.
Amgen
Amgen